Because billionaire investors can have a disproportionately large impact on how markets behave in the short term, their buys and sells tend to be closely scrutinized. And controversial hedge-fund manager George Soros is one of the most widely watched superinvestors on Wall Street, stemming from his uncanny ability to build market-crushing portfolios, time and again.
Last week's 13F filings with the SEC gave us an overview of Soros' market activity in the fourth quarter, and the billionaire surprisingly decided to dump three top dividend payers in the healthcare sector. Specifically, he sold off his entire positions in drugmakers AbbVie (NYSE: ABBV) and AstraZeneca plc (NYSE: AZN) and continued slashing his stake in the world's largest generic-drug manufacturer, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA). As dividend stocks are generally viewed as long-term buys given that they generate income, Soros' decision to sell these stocks might be something people view as a major red flag.
Source: Motley Fool
Related Articles:
- 4 Dividend Stocks For A Confident And Secure Future
- High-Yield, High-Return Investments To Increase Income While Waiting On Dividend Growth
- The Most Important Financial Statement When Selecting Dividend Growth Stocks
- 5 Five-Star Dividend Stocks
- 5 Dividend Stocks Delivering The Secret To Successful Investing
________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.